financetom
Business
financetom
/
Business
/
US FDA approves AbbVie's treatment for intra-abdominal infections
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FDA approves AbbVie's treatment for intra-abdominal infections
Feb 7, 2025 10:58 AM

Feb 7 (Reuters) - AbbVie ( ABBV ) said that the U.S.

Food and Drug Administration approved its drug for complicated

intra-abdominal infections on Friday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Eli Lilly Plans to Launch Investigational Weight Loss Drug Orforglipron in India
Market Chatter: Eli Lilly Plans to Launch Investigational Weight Loss Drug Orforglipron in India
Sep 25, 2025
07:24 AM EDT, 09/25/2025 (MT Newswires) -- Eli Lilly ( LLY ) plans to introduce its experimental weight loss pill orforglipron in India, Reuters reported Thursday, citing a senior executive. Orforglipron, a GLP-1 receptor agonist like Lilly's Mounjaro and Zepbound injectables, has shown better results than Novo Nordisk's (NVO) Rybelsus in lowering blood sugar and weight in patients with type...
Meta Ordered by Singapore to Curb Facebook Impersonation Scams, Faces Fine of up to $776,000
Meta Ordered by Singapore to Curb Facebook Impersonation Scams, Faces Fine of up to $776,000
Sep 25, 2025
07:20 AM EDT, 09/25/2025 (MT Newswires) -- Meta Platforms ( META ) was directed to deploy anti-impersonation safeguards on Facebook after Singapore issued an Implementation Directive on Wednesday, with compliance due by Tuesday, the Singapore Ministry of Home Affairs said Thursday. The order, the first under the Online Criminal Harms Act, was issued by the authority in the Singapore Police...
DarioHealth Weighs Big Moves After Surprise Interest From Suitors
DarioHealth Weighs Big Moves After Surprise Interest From Suitors
Sep 25, 2025
DarioHealth Corp. ( DRIO ) said Thursday that its board has begun a strategic review following unsolicited interest from potential partners. The New York-based digital health company, which develops chronic condition management platforms, formed a special committee of independent directors to explore options, including a sale, merger, or continuation as a standalone business. The committee hired Perella Weinberg Partners as...
Cadeler Says First A-Class Wind Installation Vessel Received
Cadeler Says First A-Class Wind Installation Vessel Received
Sep 25, 2025
07:23 AM EDT, 09/25/2025 (MT Newswires) -- Cadeler ( CDLR ) said Thursday it has taken delivery of the first Wind Ally A-class wind installation vessel following two years of construction in China. The company said Wind Ally was delivered within budget and ahead of schedule, and is the first of the three A-class vessels it had ordered. The second...
Copyright 2023-2026 - www.financetom.com All Rights Reserved